Shl Telemedicine Ltd. · SIX:SHLTN
Shl Telemedicine — FY2020 Earnings Presentation
22 slides from Shl Telemedicine's earnings presentation, Apr 13, 2021
Slide 1: SHL Telemedicine Full Year Results 2020 Presentation
SHL Telemedicine Full Year Results 2020 Presentation
Slide 2: Forward looking statements
Forward looking statements This presentation contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or ac
Slide 3: SHL Telemedicine - significantly reduces mortality, improves quality of life, and reduces healthcare costs
SHL Telemedicine - significantly reduces mortality, improves quality of life, and reduces healthcare costs • Develops technologies, solutions, and advanced telemedicine services, for diagnosis and monitoring of the heart and various chronic diseases • A leading telemedicine provider in Israel and Ge
Slide 4: SHL accelerates its global telemedicine operations for rapid implementation of proven technologies and services
SHL accelerates its global telemedicine operations for rapid implementation of proven technologies and services Use of A.I Technology (Artificial-Intelligence) Use of large databases (Big-Data) Collaboration with leading strategic healthcare industry partners Realization of growth potential in exist
Slide 5: SmartHeart Unique Advanced Technology
SmartHeart Unique Advanced Technology Cloud-based patented technology The only solution to perform a full 12 Lead personal ECG without assistance from a medical professional from anywhere in the world at any time within 30 seconds FDA cleared as hospital grade ECG (Golden Standard - 12 Lead) Thousan
Slide 6: 2020 - Summary overview - Significant progress in achieving SHL's business goals
2020 - Summary overview - Significant progress in achieving SHL's business goals • Disruptive event in Germany – July 2020 – coming into effect of regulation supporting shift to telemedicine services, as well as entrance of international players into the market • December 2020 – signing a contract w
Slide 7: Israel - steady cash flow with growth potential
Israel - steady cash flow with growth potential B2C model - sale of cardiac monitoring services to consumers: personal 12 Lead ECG device for transmission of remote medical data, 24/7 telemedicine center, electronic personal medical record, Mobile Intensive Care Units in coverage areas • About 50,00
Slide 8: Germany – New legislation supports Telemedicine services
Germany – New legislation supports Telemedicine services • Insured population of about 82 million by about 70 Sick Funds (Healthcare Insurances) • The four largest Sick Funds each serve about 5 to 10 million insured lives • The German healthcare services market amounts to about $ 110 billion per yea
Slide 9: Germany – Expected step change in scope of activity
Germany – Expected step change in scope of activity • SHL is the market leader in Germany operating a B2B model - monitors and stabilizes chronic patients and saves costs for the Sick Funds • The Company has agreements with leading Sick Funds covering about 25% of the German health insurance market
Slide 10: USA – Shift to telemedicine services is "here to stay"
USA – Shift to telemedicine services is “here to stay” • In recent years, especially in 2020, a significant increase in telemedicine services, especially of Doctor’s Virtual Visits and leading Fortune 500 companies (Amazon, Philips) have entered this field • Regulatory change - COVID-19 driven inter
Slide 11: USA – Strategic collaborations with leading healthcare industry partners
USA – Strategic collaborations with leading healthcare industry partners The goal: not to send the patient to the ECG, but send the ECG to the patient – remote cardiac monitoring, using SmartHeart • Collaboration with Mayo Clinic, a US tier 1 medical institution, to provide patients with SmartHeart
Slide 12: USA – Significant progress with additional strategic partners expected already in 2021
USA – Significant progress with additional strategic partners expected already in 2021 Collaboration with leading healthcare industry partners Clinics and nursing homes Retail chains and distributors OTC and private costumers
Slide 13: USA – The business potential
USA – The business potential Simulation of the development in annual revenues from sale of devices and services at an average of $ 40 per SmartHeart / user per month, within 5-10 years $1,250 2.50 Revenue from SmartHeart sales and cardiac 2.25 $1,000 $960 MM 2.00 monitoring services 1.75 Units/Users
Slide 14: Comparable Companies - healthcare telemedicine
Comparable Companies - healthcare telemedicine LTM Revenues Market Cap Ticker Company (USD $ M) (USD $ M) 1,093 26,900 NYSE:TDOC Teladoc 380 5,290 NASDAQ:ONEM 1Life Healthcare 245 4,290 NYSE:AMWL American Well Irhythm 265 4,000 NASDAQ:IRTC Technologies Biotelemetry - Acquired by Phillips in December
Slide 15: Financials – P&L
Financials – P&L in USD million FY2020 FY2019 FY2019 CC* (except per share amounts) Revenues for the period** 40.1 39.9 41.0 Revenues by territories · Germany 17.0 18.6 18.9 · Israel 22.5 21.1 21.9 · Other 0.6 0.2 0.2 Adjusted EBIT*** 2.2 3.7 3.8 Adjusted EBITDA*** 7.1 7.6 7.8 Net income 0.3 5.7 5.8
Slide 16: Financials - Balance Sheet and Cash Flow
Financials - Balance Sheet and Cash Flow in USD million FY2020 FY2019 (except per share amounts) Cash and cash equivalents 4.1 6.1 Short term investments 6.5 - Total cash and ST investments 10.6* 6.1 Short term debt 2.3** - Current maturities - - Long term debt - - Total Debt 2.3** - Capital and res
Slide 17: Why now? Telemedicine services became standard and are "here to stay"
Why now? Telemedicine services became standard and are “here to stay” • The outbreak of COVID-19 illustrates the importance and the many benefits of telemedicine and the need to implement technological solutions comprehensively and to track, diagnose, offer treatment and provide ongoing care for pat
Slide 18: Value Creating Events
Value Creating Events • Expansion of Doctor’s Virtual Visits activity in Germany • Additional contracts for monitoring patients in Germany • Additional Strategic Collaborations in the US • Collaborations with Additional Hospitals in the US • Implementing of first AI tools in the SmartHeart Platform
Slide 19: Key Opinion Leaders in the medical field
Key Opinion Leaders in the medical field Claus Prof. Dr. Prof. Prof. Moldenhauer Ofer Amir Helmut Platzer Wolfgang-Michael Amir Lerman Franz Former CEO of DAK, MD Former CEO MD one of the largest Head of the Cardiology AOK Bayern Sick Fund SHL Germany MAYO CLINIC German Sick Funds Department Hadassa
Slide 20: Key Leaders – SHL USA
Key Leaders – SHL USA Dr. Jonathan Fialkow Dr. Ricardo Martinez Robert Brooks Andrei Soran Chief of Cardiology, Emory University Senior Advisor for Board Member of Baptist Hospital of School of Medicine; Strategy; until recently SHL USA CEO of a health system Miami; Previously held roles at a Senior
Slide 21: Senior Management
Senior Management Yossi Vadnagra Linus Drop Erez Nachtomy Yariv Alroy CFO Managing Director CEO Chairman of the Board SHL Germany
Slide 22: Thank you
Thank you